Government caps margins on non-scheduled anti-cancer drugs at 30% of MRP
The Government approved a cap on trade margins for non-scheduled anti-cancer drugs at 30% of the Maximum Retail Price, which is expected to cut prices by up to 70%.
- Cancer patients are expected to save about Rs 2,500 crore a year.